Association between the expression of TLR4, TLR2, and MyD88 with low-grade chronic inflammation in individuals with metabolically healthy obesity

Background Among the Toll-like receptors (TLR) that are dependent of myeloid response protein (MyD88), the TLR4 and TLR2 are directly associated with low-grade chronic inflammation; however, they are not been investigated in subjects with metabolically healthy obesity (MHO). Thus, the objective of t...

Full description

Saved in:
Bibliographic Details
Published inMolecular biology reports Vol. 50; no. 5; pp. 4723 - 4728
Main Authors Guerrero-Romero, Fernando, Castellanos-Juárez, Francisco X., Salas-Pacheco, Jose M., Morales-Gurrola, Francisco G., Salas-Leal, Alma Cristina, Simental-Mendía, Luis E.
Format Journal Article
LanguageEnglish
Published Dordrecht Springer Netherlands 01.05.2023
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Among the Toll-like receptors (TLR) that are dependent of myeloid response protein (MyD88), the TLR4 and TLR2 are directly associated with low-grade chronic inflammation; however, they are not been investigated in subjects with metabolically healthy obesity (MHO). Thus, the objective of this study was to determine the association between the expression of TLR4, TLR2, and MyD88 with low-grade chronic inflammation in individuals with MHO. Methods and results Men and women with obesity aged 20 to 55 years were enrolled in a cross-sectional study. Individuals with MHO were allocated into the groups with and without low-grade chronic inflammation. Pregnancy, smoking, alcohol consumption, intense physical activity or sexual intercourse in the previous 72 h, diabetes, high blood pressure, cancer, thyroid disease, acute or chronic infections, renal impairment, and hepatic diseases, were exclusion criteria. The MHO phenotype was defined by a body mass index (BMI ≥ 30 kg/m 2 ) plus one or none of the following cardiovascular risk factors: hyperglycemia, elevated blood pressure, hypertriglyceridemia, and low high-density lipoprotein cholesterol. A total of 64 individuals with MHO were enrolled and allocated into the groups with (n = 37) and without (n = 27) inflammation. The multiple logistic regression analysis indicated that TLR2 expression is significantly associated with inflammation in individuals with MHO. In the subsequent analysis adjusted by BMI, TLR2 expression remained associated with inflammation in individuals with MHO. Conclusion Our results suggest that overexpression of TLR2, but not TLR4 and MyD88, is associated with low-grade chronic inflammation in subjects with MHO.
AbstractList Among the Toll-like receptors (TLR) that are dependent of myeloid response protein (MyD88), the TLR4 and TLR2 are directly associated with low-grade chronic inflammation; however, they are not been investigated in subjects with metabolically healthy obesity (MHO). Thus, the objective of this study was to determine the association between the expression of TLR4, TLR2, and MyD88 with low-grade chronic inflammation in individuals with MHO.BACKGROUNDAmong the Toll-like receptors (TLR) that are dependent of myeloid response protein (MyD88), the TLR4 and TLR2 are directly associated with low-grade chronic inflammation; however, they are not been investigated in subjects with metabolically healthy obesity (MHO). Thus, the objective of this study was to determine the association between the expression of TLR4, TLR2, and MyD88 with low-grade chronic inflammation in individuals with MHO.Men and women with obesity aged 20 to 55 years were enrolled in a cross-sectional study. Individuals with MHO were allocated into the groups with and without low-grade chronic inflammation. Pregnancy, smoking, alcohol consumption, intense physical activity or sexual intercourse in the previous 72 h, diabetes, high blood pressure, cancer, thyroid disease, acute or chronic infections, renal impairment, and hepatic diseases, were exclusion criteria. The MHO phenotype was defined by a body mass index (BMI ≥ 30 kg/m2) plus one or none of the following cardiovascular risk factors: hyperglycemia, elevated blood pressure, hypertriglyceridemia, and low high-density lipoprotein cholesterol. A total of 64 individuals with MHO were enrolled and allocated into the groups with (n = 37) and without (n = 27) inflammation. The multiple logistic regression analysis indicated that TLR2 expression is significantly associated with inflammation in individuals with MHO. In the subsequent analysis adjusted by BMI, TLR2 expression remained associated with inflammation in individuals with MHO.METHODS AND RESULTSMen and women with obesity aged 20 to 55 years were enrolled in a cross-sectional study. Individuals with MHO were allocated into the groups with and without low-grade chronic inflammation. Pregnancy, smoking, alcohol consumption, intense physical activity or sexual intercourse in the previous 72 h, diabetes, high blood pressure, cancer, thyroid disease, acute or chronic infections, renal impairment, and hepatic diseases, were exclusion criteria. The MHO phenotype was defined by a body mass index (BMI ≥ 30 kg/m2) plus one or none of the following cardiovascular risk factors: hyperglycemia, elevated blood pressure, hypertriglyceridemia, and low high-density lipoprotein cholesterol. A total of 64 individuals with MHO were enrolled and allocated into the groups with (n = 37) and without (n = 27) inflammation. The multiple logistic regression analysis indicated that TLR2 expression is significantly associated with inflammation in individuals with MHO. In the subsequent analysis adjusted by BMI, TLR2 expression remained associated with inflammation in individuals with MHO.Our results suggest that overexpression of TLR2, but not TLR4 and MyD88, is associated with low-grade chronic inflammation in subjects with MHO.CONCLUSIONOur results suggest that overexpression of TLR2, but not TLR4 and MyD88, is associated with low-grade chronic inflammation in subjects with MHO.
BACKGROUND: Among the Toll-like receptors (TLR) that are dependent of myeloid response protein (MyD88), the TLR4 and TLR2 are directly associated with low-grade chronic inflammation; however, they are not been investigated in subjects with metabolically healthy obesity (MHO). Thus, the objective of this study was to determine the association between the expression of TLR4, TLR2, and MyD88 with low-grade chronic inflammation in individuals with MHO. METHODS AND RESULTS: Men and women with obesity aged 20 to 55 years were enrolled in a cross-sectional study. Individuals with MHO were allocated into the groups with and without low-grade chronic inflammation. Pregnancy, smoking, alcohol consumption, intense physical activity or sexual intercourse in the previous 72 h, diabetes, high blood pressure, cancer, thyroid disease, acute or chronic infections, renal impairment, and hepatic diseases, were exclusion criteria. The MHO phenotype was defined by a body mass index (BMI ≥ 30 kg/m²) plus one or none of the following cardiovascular risk factors: hyperglycemia, elevated blood pressure, hypertriglyceridemia, and low high-density lipoprotein cholesterol. A total of 64 individuals with MHO were enrolled and allocated into the groups with (n = 37) and without (n = 27) inflammation. The multiple logistic regression analysis indicated that TLR2 expression is significantly associated with inflammation in individuals with MHO. In the subsequent analysis adjusted by BMI, TLR2 expression remained associated with inflammation in individuals with MHO. CONCLUSION: Our results suggest that overexpression of TLR2, but not TLR4 and MyD88, is associated with low-grade chronic inflammation in subjects with MHO.
Among the Toll-like receptors (TLR) that are dependent of myeloid response protein (MyD88), the TLR4 and TLR2 are directly associated with low-grade chronic inflammation; however, they are not been investigated in subjects with metabolically healthy obesity (MHO). Thus, the objective of this study was to determine the association between the expression of TLR4, TLR2, and MyD88 with low-grade chronic inflammation in individuals with MHO. Men and women with obesity aged 20 to 55 years were enrolled in a cross-sectional study. Individuals with MHO were allocated into the groups with and without low-grade chronic inflammation. Pregnancy, smoking, alcohol consumption, intense physical activity or sexual intercourse in the previous 72 h, diabetes, high blood pressure, cancer, thyroid disease, acute or chronic infections, renal impairment, and hepatic diseases, were exclusion criteria. The MHO phenotype was defined by a body mass index (BMI ≥ 30 kg/m ) plus one or none of the following cardiovascular risk factors: hyperglycemia, elevated blood pressure, hypertriglyceridemia, and low high-density lipoprotein cholesterol. A total of 64 individuals with MHO were enrolled and allocated into the groups with (n = 37) and without (n = 27) inflammation. The multiple logistic regression analysis indicated that TLR2 expression is significantly associated with inflammation in individuals with MHO. In the subsequent analysis adjusted by BMI, TLR2 expression remained associated with inflammation in individuals with MHO. Our results suggest that overexpression of TLR2, but not TLR4 and MyD88, is associated with low-grade chronic inflammation in subjects with MHO.
BackgroundAmong the Toll-like receptors (TLR) that are dependent of myeloid response protein (MyD88), the TLR4 and TLR2 are directly associated with low-grade chronic inflammation; however, they are not been investigated in subjects with metabolically healthy obesity (MHO). Thus, the objective of this study was to determine the association between the expression of TLR4, TLR2, and MyD88 with low-grade chronic inflammation in individuals with MHO.Methods and resultsMen and women with obesity aged 20 to 55 years were enrolled in a cross-sectional study. Individuals with MHO were allocated into the groups with and without low-grade chronic inflammation. Pregnancy, smoking, alcohol consumption, intense physical activity or sexual intercourse in the previous 72 h, diabetes, high blood pressure, cancer, thyroid disease, acute or chronic infections, renal impairment, and hepatic diseases, were exclusion criteria. The MHO phenotype was defined by a body mass index (BMI ≥ 30 kg/m2) plus one or none of the following cardiovascular risk factors: hyperglycemia, elevated blood pressure, hypertriglyceridemia, and low high-density lipoprotein cholesterol. A total of 64 individuals with MHO were enrolled and allocated into the groups with (n = 37) and without (n = 27) inflammation. The multiple logistic regression analysis indicated that TLR2 expression is significantly associated with inflammation in individuals with MHO. In the subsequent analysis adjusted by BMI, TLR2 expression remained associated with inflammation in individuals with MHO.ConclusionOur results suggest that overexpression of TLR2, but not TLR4 and MyD88, is associated with low-grade chronic inflammation in subjects with MHO.
Background Among the Toll-like receptors (TLR) that are dependent of myeloid response protein (MyD88), the TLR4 and TLR2 are directly associated with low-grade chronic inflammation; however, they are not been investigated in subjects with metabolically healthy obesity (MHO). Thus, the objective of this study was to determine the association between the expression of TLR4, TLR2, and MyD88 with low-grade chronic inflammation in individuals with MHO. Methods and results Men and women with obesity aged 20 to 55 years were enrolled in a cross-sectional study. Individuals with MHO were allocated into the groups with and without low-grade chronic inflammation. Pregnancy, smoking, alcohol consumption, intense physical activity or sexual intercourse in the previous 72 h, diabetes, high blood pressure, cancer, thyroid disease, acute or chronic infections, renal impairment, and hepatic diseases, were exclusion criteria. The MHO phenotype was defined by a body mass index (BMI ≥ 30 kg/m 2 ) plus one or none of the following cardiovascular risk factors: hyperglycemia, elevated blood pressure, hypertriglyceridemia, and low high-density lipoprotein cholesterol. A total of 64 individuals with MHO were enrolled and allocated into the groups with (n = 37) and without (n = 27) inflammation. The multiple logistic regression analysis indicated that TLR2 expression is significantly associated with inflammation in individuals with MHO. In the subsequent analysis adjusted by BMI, TLR2 expression remained associated with inflammation in individuals with MHO. Conclusion Our results suggest that overexpression of TLR2, but not TLR4 and MyD88, is associated with low-grade chronic inflammation in subjects with MHO.
Author Morales-Gurrola, Francisco G.
Salas-Leal, Alma Cristina
Guerrero-Romero, Fernando
Simental-Mendía, Luis E.
Salas-Pacheco, Jose M.
Castellanos-Juárez, Francisco X.
Author_xml – sequence: 1
  givenname: Fernando
  surname: Guerrero-Romero
  fullname: Guerrero-Romero, Fernando
  organization: Unidad de Investigación Biomédica, Instituto Mexicano del Seguro Social
– sequence: 2
  givenname: Francisco X.
  surname: Castellanos-Juárez
  fullname: Castellanos-Juárez, Francisco X.
  organization: Institute of Scientific Research, Juarez University of the State of Durango
– sequence: 3
  givenname: Jose M.
  surname: Salas-Pacheco
  fullname: Salas-Pacheco, Jose M.
  organization: Institute of Scientific Research, Juarez University of the State of Durango
– sequence: 4
  givenname: Francisco G.
  surname: Morales-Gurrola
  fullname: Morales-Gurrola, Francisco G.
  organization: Unidad de Investigación Biomédica, Instituto Mexicano del Seguro Social, Institute of Scientific Research, Juarez University of the State of Durango
– sequence: 5
  givenname: Alma Cristina
  surname: Salas-Leal
  fullname: Salas-Leal, Alma Cristina
  organization: Institute of Scientific Research, Juarez University of the State of Durango
– sequence: 6
  givenname: Luis E.
  orcidid: 0000-0002-3617-4921
  surname: Simental-Mendía
  fullname: Simental-Mendía, Luis E.
  email: luis_simental81@hotmail.com
  organization: Unidad de Investigación Biomédica, Instituto Mexicano del Seguro Social
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36905405$$D View this record in MEDLINE/PubMed
BookMark eNqFkc9u1DAQhy1URLeFF-CALHHh0MA4dhzvsSp_pUVIqJwjx540rpJ4sR2W9C14Y5KmgNRDkWyPZH2_8VjfCTka_ICEPGfwmgGUbyJjwHkG-bwV5yq7eUQ2rCh5JralOiIb4MAyoQp2TE5ivAYAwcriCTnmcguFgGJDfp3H6I3TyfmB1pgOiANNLVL8uQ8Y43LtG3q5-yrOljM_o3qw9PP0Vil6cKmlnT9kV0FbpKYNfnCGuqHpdN-vPd2yrPvh7Ki7uEZ6TLr2nTO66ybaou5SO1FfY3RpekoeNzOJz-7qKfn2_t3lxcds9-XDp4vzXWYEqJQxaRWUDUojEbCWWNSGbbc1NkZIboSxYJnN5dYCWGGkAlbWVlrTWIG8zPkpebX23Qf_fcSYqt5Fg12nB_RjrDgrOCvVUv6H5qWSDJiQckZf3kOv_RiG-SNVPs-b51yIhXpxR411j7baB9frMFV_vMxAvgIm-BgDNn8RBtUiv1rlV7P86lZ-dTOH1L2QcenWQgradQ9H-RqN8zvDFYZ_Yz-Q-g2DTcS3
CitedBy_id crossref_primary_10_1007_s00774_025_01594_y
crossref_primary_10_1038_s41575_023_00867_z
crossref_primary_10_3389_frmbi_2024_1324476
crossref_primary_10_1007_s11657_024_01424_0
crossref_primary_10_1016_j_biochi_2025_01_008
crossref_primary_10_1016_j_surg_2023_07_002
crossref_primary_10_1186_s12889_024_20243_z
crossref_primary_10_1016_j_intimp_2024_111551
crossref_primary_10_3389_fendo_2023_1191501
crossref_primary_10_1007_s10067_024_07179_w
crossref_primary_10_1302_2046_3758_1310_BJR_2023_0366_R1
Cites_doi 10.3109/13813455.2011.562514
10.1038/SJ.IJO.0801792
10.1002/JCSM.12159
10.2337/DC11-2375
10.1210/JC.2014-3885
10.1016/S0140-6736(10)62037-5
10.1038/OBY.2003.74
10.1080/13813450802181047
10.1016/J.METABOL.2019.01.003
10.1007/S00125-010-1747-3
10.1139/Y11-071
10.3390/metabo10020048
10.1677/JOE-08-0354
10.2337/DC09-1799
10.1097/MD.0000000000003384
10.2337/DB20-0591
10.1089/MET.2008.0034
10.1210/ENDREV/BNAA004
10.1210/JC.2005-0482
10.1159/000191413
10.3389/FIMMU.2014.00461
10.1385/IR:34:3:193
10.1016/J.DIABRES.2004.11.007
10.1373/49.4.666
10.1210/JC.2010-0288
10.1038/OBY.2008.25
10.1111/J.2047-6310.2012.00098.X
10.1038/SJ.IJO.0803304
10.1371/JOURNAL.PONE.0265362
10.7554/ELIFE.31377
10.3389/FENDO.2022.886957
10.1186/1476-9255-9-48
10.1210/JC.2013-2038
10.1097/MD.0000000000008838
10.1161/CIRCULATIONAHA.109.192644
10.1161/01.HYP.0000107251.49515.C2
10.1186/S12950-014-0039-Y
10.1371/JOURNAL.PONE.0121971
10.1371/JOURNAL.PONE.0214468
10.1161/JAHA.115.002823
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer Nature B.V. 2023
2023. The Author(s), under exclusive licence to Springer Nature B.V.
The Author(s), under exclusive licence to Springer Nature B.V. 2023.
Copyright_xml – notice: The Author(s), under exclusive licence to Springer Nature B.V. 2023
– notice: 2023. The Author(s), under exclusive licence to Springer Nature B.V.
– notice: The Author(s), under exclusive licence to Springer Nature B.V. 2023.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7TM
7X7
7XB
88A
88E
88I
8AO
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
RC3
7X8
7S9
L.6
DOI 10.1007/s11033-023-08338-z
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Nucleic Acids Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Science Database
Biological Science Database
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
Genetics Abstracts
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList MEDLINE - Academic
AGRICOLA
MEDLINE
ProQuest Central Student

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
EISSN 1573-4978
EndPage 4728
ExternalDocumentID 36905405
10_1007_s11033_023_08338_z
Genre Journal Article
GroupedDBID ---
-4W
-56
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
123
1SB
203
28-
29M
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3SX
3V.
4.4
406
408
409
40E
53G
5QI
5RE
5VS
67N
67Z
6NX
78A
7X7
88A
88E
88I
8AO
8FE
8FH
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHBH
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACGOD
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACZOJ
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYPR
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFGCZ
AFKRA
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B-.
BA0
BBNVY
BBWZM
BDATZ
BENPR
BGNMA
BHPHI
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
DWQXO
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
EPAXT
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ6
GQ7
GQ8
GXS
H13
HCIFZ
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAK
LK8
LLZTM
M0L
M1P
M2P
M4Y
M7P
MA-
N2Q
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
RNS
ROL
RPX
RRX
RSV
RZC
RZE
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SBY
SCLPG
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TEORI
TSG
TSK
TSV
TUC
TUS
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WH7
WJK
WK6
WK8
YLTOR
Z45
Z7U
Z7V
Z7W
Z7Y
Z82
Z83
Z87
Z8O
Z8P
Z8Q
Z8S
Z8V
Z8W
Z91
ZMTXR
ZOVNA
ZXP
~A9
~EX
~KM
AAPKM
AAYXX
ABAKF
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7TM
7XB
8FD
8FK
ABRTQ
FR3
K9.
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
Q9U
RC3
7X8
7S9
L.6
ID FETCH-LOGICAL-c408t-16d807fe6c6e0eb6e5bc199befc463c4cd0d1d269d00d4c68017bd6dcfd4e3723
IEDL.DBID U2A
ISSN 0301-4851
1573-4978
IngestDate Tue Aug 05 09:59:32 EDT 2025
Fri Jul 11 04:13:44 EDT 2025
Fri Jul 25 18:55:45 EDT 2025
Wed Feb 19 02:24:51 EST 2025
Tue Jul 01 03:18:28 EDT 2025
Thu Apr 24 23:02:40 EDT 2025
Fri Feb 21 02:45:30 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Obesity
Inflammation
TLR
Metabolically healthy obesity
MyD88
Language English
License 2023. The Author(s), under exclusive licence to Springer Nature B.V.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c408t-16d807fe6c6e0eb6e5bc199befc463c4cd0d1d269d00d4c68017bd6dcfd4e3723
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-3617-4921
PMID 36905405
PQID 2807223446
PQPubID 54080
PageCount 6
ParticipantIDs proquest_miscellaneous_3153178315
proquest_miscellaneous_2786101466
proquest_journals_2807223446
pubmed_primary_36905405
crossref_primary_10_1007_s11033_023_08338_z
crossref_citationtrail_10_1007_s11033_023_08338_z
springer_journals_10_1007_s11033_023_08338_z
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20230500
2023-05-00
2023-May
20230501
PublicationDateYYYYMMDD 2023-05-01
PublicationDate_xml – month: 5
  year: 2023
  text: 20230500
PublicationDecade 2020
PublicationPlace Dordrecht
PublicationPlace_xml – name: Dordrecht
– name: Netherlands
PublicationSubtitle An International Journal on Molecular and Cellular Biology
PublicationTitle Molecular biology reports
PublicationTitleAbbrev Mol Biol Rep
PublicationTitleAlternate Mol Biol Rep
PublicationYear 2023
Publisher Springer Netherlands
Springer Nature B.V
Publisher_xml – name: Springer Netherlands
– name: Springer Nature B.V
References Dasu, Devaraj, Park, Jialal (CR22) 2010; 33
Park, Park, Yu (CR31) 2005; 69
CR19
CR18
Vitseva, Tanriverdi, Tchkonia (CR11) 2008; 16
Guo, Zhang, Liu (CR30) 2021; 70
Shin, Hyun, Kim (CR36) 2006; 30
Jung, Lee, Kang (CR37) 2015; 100
Kim, Seo, Cho (CR2) 2016; 95
CR13
CR12
CR10
Hardy, Kim, Ciccarelli (CR20) 2013; 8
Karelis, Faraj, Bastard (CR8) 2005; 90
Simental-Mendía, Rodríguez-Morán, Guerrero-Romero (CR16) 2008; 6
Bulló, García-Lorda, Megias, Salas-Salvadó (CR34) 2003; 11
Mullick, Tobias, Curtiss (CR26) 2006; 34
Guerrero-Romero, Simental-Mendía, González-Ortiz (CR15) 2010; 95
Brandão, Martins, Monteiro (CR1) 2020; 10
CR4
Kawasaki, Kawai (CR24) 2014
CR6
Fresno, Alvarez, Cuesta (CR9) 2011; 117
CR5
Rifai, Ridker (CR14) 2003; 49
Gonzalez, Heymsfield (CR17) 2017; 8
Jialal, Huet, Kaur (CR21) 2012; 35
CR7
Blüher (CR39) 2020; 41
Ehses, Meier, Wueest (CR29) 2010; 53
Erridge (CR25) 2009; 1
Finucane, Stevens, Cowan (CR3) 2011; 377
CR23
CR41
CR40
Kouvari, Panagiotakos, Yannakoulia (CR38) 2019; 93
Caricilli, Nascimento, Pauli (CR28) 2008; 199
Nieto-Vazquez, Fernández-Veledo, Krämer (CR35) 2008; 114
Festa, D’Agostino, Williams (CR33) 2001; 25
Bastard, Maachi, Lagathu (CR32) 2006; 17
Hasu, Thabet, Tam, Whitman (CR27) 2011; 89
J-P Bastard (8338_CR32) 2006; 17
OI Vitseva (8338_CR11) 2008; 16
8338_CR13
MC Gonzalez (8338_CR17) 2017; 8
NH Kim (8338_CR2) 2016; 95
8338_CR19
F Guerrero-Romero (8338_CR15) 2010; 95
8338_CR18
I Nieto-Vazquez (8338_CR35) 2008; 114
8338_CR12
MR Dasu (8338_CR22) 2010; 33
8338_CR10
AM Caricilli (8338_CR28) 2008; 199
M Fresno (8338_CR9) 2011; 117
OT Hardy (8338_CR20) 2013; 8
AE Mullick (8338_CR26) 2006; 34
C Erridge (8338_CR25) 2009; 1
8338_CR6
8338_CR7
AD Karelis (8338_CR8) 2005; 90
HS Park (8338_CR31) 2005; 69
T Kawasaki (8338_CR24) 2014
LE Simental-Mendía (8338_CR16) 2008; 6
M Bulló (8338_CR34) 2003; 11
N Rifai (8338_CR14) 2003; 49
MM Finucane (8338_CR3) 2011; 377
I Jialal (8338_CR21) 2012; 35
Z Guo (8338_CR30) 2021; 70
8338_CR4
8338_CR5
8338_CR41
8338_CR40
I Brandão (8338_CR1) 2020; 10
8338_CR23
A Festa (8338_CR33) 2001; 25
CH Jung (8338_CR37) 2015; 100
JA Ehses (8338_CR29) 2010; 53
M Hasu (8338_CR27) 2011; 89
M Blüher (8338_CR39) 2020; 41
MJ Shin (8338_CR36) 2006; 30
M Kouvari (8338_CR38) 2019; 93
References_xml – volume: 117
  start-page: 151
  year: 2011
  end-page: 164
  ident: CR9
  article-title: Toll-like receptors, inflammation, metabolism and obesity
  publication-title: Arch Physiol Biochem
  doi: 10.3109/13813455.2011.562514
– volume: 25
  start-page: 1407
  year: 2001
  end-page: 1415
  ident: CR33
  article-title: The relation of body fat mass and distribution to markers of chronic inflammation
  publication-title: Int J Obes Relat Metab Disord
  doi: 10.1038/SJ.IJO.0801792
– ident: CR18
– volume: 8
  start-page: 187
  year: 2017
  end-page: 189
  ident: CR17
  article-title: Bioelectrical impedance analysis for diagnosing sarcopenia and cachexia: what are we really estimating?
  publication-title: J Cachexia Sarcopenia Muscle
  doi: 10.1002/JCSM.12159
– volume: 35
  start-page: 900
  year: 2012
  end-page: 904
  ident: CR21
  article-title: Increased toll-like receptor activity in patients with metabolic syndrome
  publication-title: Diabetes Care
  doi: 10.2337/DC11-2375
– volume: 100
  start-page: 934
  year: 2015
  end-page: 941
  ident: CR37
  article-title: The risk of incident type 2 diabetes in a korean metabolically healthy obese population: the role of systemic inflammation
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/JC.2014-3885
– volume: 377
  start-page: 557
  year: 2011
  end-page: 567
  ident: CR3
  article-title: National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants
  publication-title: Lancet (London England)
  doi: 10.1016/S0140-6736(10)62037-5
– volume: 11
  start-page: 525
  year: 2003
  end-page: 531
  ident: CR34
  article-title: Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression
  publication-title: Obes Res
  doi: 10.1038/OBY.2003.74
– ident: CR4
– ident: CR12
– volume: 114
  start-page: 183
  year: 2008
  end-page: 194
  ident: CR35
  article-title: Insulin resistance associated to obesity: the link TNF-alpha
  publication-title: Arch Physiol Biochem
  doi: 10.1080/13813450802181047
– volume: 93
  start-page: 18
  year: 2019
  end-page: 24
  ident: CR38
  article-title: Transition from metabolically benign to metabolically unhealthy obesity and 10-year cardiovascular disease incidence: the ATTICA cohort study
  publication-title: Metabolism
  doi: 10.1016/J.METABOL.2019.01.003
– ident: CR10
– volume: 53
  start-page: 1795
  year: 2010
  end-page: 1806
  ident: CR29
  article-title: Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet
  publication-title: Diabetologia
  doi: 10.1007/S00125-010-1747-3
– volume: 17
  start-page: 4
  year: 2006
  end-page: 12
  ident: CR32
  article-title: Recent advances in the relationship between obesity, inflammation, and insulin resistance
  publication-title: Eur Cytokine Netw
– ident: CR6
– volume: 89
  start-page: 737
  year: 2011
  end-page: 742
  ident: CR27
  article-title: Specific loss of toll-like receptor 2 on bone marrow derived cells decreases atherosclerosis in LDL receptor null mice
  publication-title: Can J Physiol Pharmacol
  doi: 10.1139/Y11-071
– ident: CR40
– ident: CR23
– volume: 10
  start-page: 48
  year: 2020
  ident: CR1
  article-title: Metabolically healthy obesity—heterogeneity in definitions and unconventional factors
  publication-title: Metabolites
  doi: 10.3390/metabo10020048
– volume: 199
  start-page: 399
  year: 2008
  end-page: 406
  ident: CR28
  article-title: Inhibition of toll-like receptor 2 expression improves insulin sensitivity and signaling in muscle and white adipose tissue of mice fed a high-fat diet
  publication-title: J Endocrinol
  doi: 10.1677/JOE-08-0354
– volume: 33
  start-page: 861
  year: 2010
  end-page: 868
  ident: CR22
  article-title: Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects
  publication-title: Diabetes Care
  doi: 10.2337/DC09-1799
– ident: CR19
– volume: 95
  start-page: e3384
  year: 2016
  ident: CR2
  article-title: Risk of the Development of Diabetes and Cardiovascular Disease in metabolically healthy obese people
  publication-title: Med (Baltim)
  doi: 10.1097/MD.0000000000003384
– ident: CR13
– volume: 70
  start-page: 2107
  year: 2021
  end-page: 2119
  ident: CR30
  article-title: Toll-like receptor 2 (TLR2) knockout abrogates Diabetic and obese phenotypes while restoring endothelial function via inhibition of NOX1
  publication-title: Diabetes
  doi: 10.2337/DB20-0591
– volume: 6
  start-page: 299
  year: 2008
  end-page: 304
  ident: CR16
  article-title: The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects
  publication-title: Metab Syndr Relat Disord
  doi: 10.1089/MET.2008.0034
– volume: 41
  start-page: 405
  year: 2020
  end-page: 420
  ident: CR39
  article-title: Metabolically healthy obesity
  publication-title: Endocr Rev
  doi: 10.1210/ENDREV/BNAA004
– volume: 90
  start-page: 4145
  year: 2005
  end-page: 4150
  ident: CR8
  article-title: The metabolically healthy but obese individual presents a favorable inflammation profile
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/JC.2005-0482
– volume: 1
  start-page: 340
  year: 2009
  end-page: 349
  ident: CR25
  article-title: The roles of toll-like receptors in atherosclerosis
  publication-title: J Innate Immun
  doi: 10.1159/000191413
– ident: CR5
– year: 2014
  ident: CR24
  article-title: Toll-like receptor signaling pathways
  publication-title: Front Immunol
  doi: 10.3389/FIMMU.2014.00461
– volume: 34
  start-page: 193
  year: 2006
  end-page: 209
  ident: CR26
  article-title: Toll-like receptors and atherosclerosis: key contributors in disease and health?
  publication-title: Immunol Res
  doi: 10.1385/IR:34:3:193
– volume: 69
  start-page: 29
  year: 2005
  end-page: 35
  ident: CR31
  article-title: Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/J.DIABRES.2004.11.007
– ident: CR7
– volume: 49
  start-page: 666
  year: 2003
  end-page: 669
  ident: CR14
  article-title: Population distributions of C-reactive protein in apparently healthy men and women in the United States: implication for clinical interpretation
  publication-title: Clin Chem
  doi: 10.1373/49.4.666
– volume: 95
  start-page: 3347
  year: 2010
  end-page: 3351
  ident: CR15
  article-title: The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/JC.2010-0288
– volume: 16
  start-page: 932
  year: 2008
  end-page: 937
  ident: CR11
  article-title: Inducible toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue
  publication-title: Obes (Silver Spring)
  doi: 10.1038/OBY.2008.25
– ident: CR41
– volume: 8
  start-page: e19
  year: 2013
  end-page: e23
  ident: CR20
  article-title: Increased toll-like receptor (TLR) mRNA expression in monocytes is a feature of metabolic syndrome in adolescents
  publication-title: Pediatr Obes
  doi: 10.1111/J.2047-6310.2012.00098.X
– volume: 30
  start-page: 1529
  year: 2006
  end-page: 1534
  ident: CR36
  article-title: Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women
  publication-title: Int J Obes (Lond)
  doi: 10.1038/SJ.IJO.0803304
– ident: 8338_CR40
  doi: 10.1371/JOURNAL.PONE.0265362
– ident: 8338_CR10
  doi: 10.7554/ELIFE.31377
– volume: 25
  start-page: 1407
  year: 2001
  ident: 8338_CR33
  publication-title: Int J Obes Relat Metab Disord
  doi: 10.1038/SJ.IJO.0801792
– volume: 8
  start-page: 187
  year: 2017
  ident: 8338_CR17
  publication-title: J Cachexia Sarcopenia Muscle
  doi: 10.1002/JCSM.12159
– volume: 377
  start-page: 557
  year: 2011
  ident: 8338_CR3
  publication-title: Lancet (London England)
  doi: 10.1016/S0140-6736(10)62037-5
– volume: 89
  start-page: 737
  year: 2011
  ident: 8338_CR27
  publication-title: Can J Physiol Pharmacol
  doi: 10.1139/Y11-071
– year: 2014
  ident: 8338_CR24
  publication-title: Front Immunol
  doi: 10.3389/FIMMU.2014.00461
– volume: 41
  start-page: 405
  year: 2020
  ident: 8338_CR39
  publication-title: Endocr Rev
  doi: 10.1210/ENDREV/BNAA004
– volume: 1
  start-page: 340
  year: 2009
  ident: 8338_CR25
  publication-title: J Innate Immun
  doi: 10.1159/000191413
– ident: 8338_CR41
  doi: 10.3389/FENDO.2022.886957
– volume: 93
  start-page: 18
  year: 2019
  ident: 8338_CR38
  publication-title: Metabolism
  doi: 10.1016/J.METABOL.2019.01.003
– volume: 95
  start-page: e3384
  year: 2016
  ident: 8338_CR2
  publication-title: Med (Baltim)
  doi: 10.1097/MD.0000000000003384
– ident: 8338_CR23
  doi: 10.1186/1476-9255-9-48
– volume: 11
  start-page: 525
  year: 2003
  ident: 8338_CR34
  publication-title: Obes Res
  doi: 10.1038/OBY.2003.74
– volume: 6
  start-page: 299
  year: 2008
  ident: 8338_CR16
  publication-title: Metab Syndr Relat Disord
  doi: 10.1089/MET.2008.0034
– volume: 69
  start-page: 29
  year: 2005
  ident: 8338_CR31
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/J.DIABRES.2004.11.007
– ident: 8338_CR7
  doi: 10.1210/JC.2013-2038
– volume: 117
  start-page: 151
  year: 2011
  ident: 8338_CR9
  publication-title: Arch Physiol Biochem
  doi: 10.3109/13813455.2011.562514
– volume: 33
  start-page: 861
  year: 2010
  ident: 8338_CR22
  publication-title: Diabetes Care
  doi: 10.2337/DC09-1799
– volume: 199
  start-page: 399
  year: 2008
  ident: 8338_CR28
  publication-title: J Endocrinol
  doi: 10.1677/JOE-08-0354
– ident: 8338_CR4
  doi: 10.1097/MD.0000000000008838
– volume: 95
  start-page: 3347
  year: 2010
  ident: 8338_CR15
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/JC.2010-0288
– ident: 8338_CR12
  doi: 10.1161/CIRCULATIONAHA.109.192644
– ident: 8338_CR18
  doi: 10.1161/01.HYP.0000107251.49515.C2
– ident: 8338_CR19
  doi: 10.1186/S12950-014-0039-Y
– volume: 10
  start-page: 48
  year: 2020
  ident: 8338_CR1
  publication-title: Metabolites
  doi: 10.3390/metabo10020048
– volume: 34
  start-page: 193
  year: 2006
  ident: 8338_CR26
  publication-title: Immunol Res
  doi: 10.1385/IR:34:3:193
– volume: 16
  start-page: 932
  year: 2008
  ident: 8338_CR11
  publication-title: Obes (Silver Spring)
  doi: 10.1038/OBY.2008.25
– volume: 100
  start-page: 934
  year: 2015
  ident: 8338_CR37
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/JC.2014-3885
– ident: 8338_CR5
  doi: 10.1371/JOURNAL.PONE.0121971
– ident: 8338_CR13
  doi: 10.1371/JOURNAL.PONE.0214468
– volume: 49
  start-page: 666
  year: 2003
  ident: 8338_CR14
  publication-title: Clin Chem
  doi: 10.1373/49.4.666
– volume: 70
  start-page: 2107
  year: 2021
  ident: 8338_CR30
  publication-title: Diabetes
  doi: 10.2337/DB20-0591
– volume: 30
  start-page: 1529
  year: 2006
  ident: 8338_CR36
  publication-title: Int J Obes (Lond)
  doi: 10.1038/SJ.IJO.0803304
– volume: 90
  start-page: 4145
  year: 2005
  ident: 8338_CR8
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/JC.2005-0482
– volume: 114
  start-page: 183
  year: 2008
  ident: 8338_CR35
  publication-title: Arch Physiol Biochem
  doi: 10.1080/13813450802181047
– volume: 8
  start-page: e19
  year: 2013
  ident: 8338_CR20
  publication-title: Pediatr Obes
  doi: 10.1111/J.2047-6310.2012.00098.X
– volume: 53
  start-page: 1795
  year: 2010
  ident: 8338_CR29
  publication-title: Diabetologia
  doi: 10.1007/S00125-010-1747-3
– volume: 17
  start-page: 4
  year: 2006
  ident: 8338_CR32
  publication-title: Eur Cytokine Netw
– ident: 8338_CR6
  doi: 10.1161/JAHA.115.002823
– volume: 35
  start-page: 900
  year: 2012
  ident: 8338_CR21
  publication-title: Diabetes Care
  doi: 10.2337/DC11-2375
SSID ssj0004175
Score 2.4049373
Snippet Background Among the Toll-like receptors (TLR) that are dependent of myeloid response protein (MyD88), the TLR4 and TLR2 are directly associated with low-grade...
Among the Toll-like receptors (TLR) that are dependent of myeloid response protein (MyD88), the TLR4 and TLR2 are directly associated with low-grade chronic...
BackgroundAmong the Toll-like receptors (TLR) that are dependent of myeloid response protein (MyD88), the TLR4 and TLR2 are directly associated with low-grade...
BACKGROUND: Among the Toll-like receptors (TLR) that are dependent of myeloid response protein (MyD88), the TLR4 and TLR2 are directly associated with...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 4723
SubjectTerms Adaptor Proteins, Signal Transducing - metabolism
alcohol drinking
Animal Anatomy
Animal Biochemistry
Biomedical and Life Sciences
Blood pressure
Body Mass Index
Cardiovascular diseases
Cholesterol
Cross-Sectional Studies
diabetes
Diabetes mellitus
Female
High density lipoprotein
high density lipoprotein cholesterol
Histology
Humans
Hyperglycemia
Hypertension
Hypertension - metabolism
Hypertriglyceridemia
Inflammation
Inflammation - genetics
Life Sciences
Liver diseases
Morphology
MyD88 protein
Myeloid Differentiation Factor 88 - genetics
Myeloid Differentiation Factor 88 - metabolism
Obesity
Obesity, Metabolically Benign
phenotype
Phenotypes
Physical activity
pregnancy
regression analysis
risk
Risk Factors
Sexual intercourse
Short Communication
Thyroid cancer
Thyroid diseases
TLR2 protein
TLR4 protein
Toll-Like Receptor 2 - genetics
Toll-Like Receptor 2 - metabolism
Toll-like receptors
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwEB1BEaIXBOUrUJCRuLERceK1kxNChapClANqpb1FscdBlZakdLcq23_BP2YmdnZBFXtJFMWWLM-zZzyemQfwptXSWeToGaxMqkhFppaOQrTiy8JPW9fiQAZz_FUfnarPs-ksOtwWMaxy3BOHjRp7xz7yd1y1hVQZnV7en_9MmTWKb1cjhcZtuMOlyziky8zMJi9SDoV22epPFZkWMWkmpM5JZjEjjcX1mWnRX_-rmG5YmzduSgcFdPgA7kfLUXwIon4It3y3B3cDl-RqD-4djNRtj-D3X5MuYiSWIEtP-F8x7rUTfStOvnxTE37mE9F0KI5XH8tSsGdWzPur9PtFg164UD1XEBIJPCHRkT7E2TqTaxG6_PBLAhT7AOfzlQj5lSvRB-KBx3B6-Onk4CiN3AupU1m5TKVGmvDWa6d95q32U-tkVVnfOqULpxxmKDHXFWYZKqdJ0RmLGkm4yhcmL57ATtd3_hkIYww6JyVK26opmkZi0VSZswQFJ_M8ATlOfO1iYXLmx5jXm5LKLKyahFUPwqqvE3i77nMeynJsbb0_yrOOS3RRbwCVwOv1bxIU35g0ne8vqY0pNZMZ6y1tCtIZ0pT0SuBpwMp6SIWuBpM4gckIns0A_j_e59vH-wJ28wG4HHa5DzvLi0v_kkyjpX014P8PZ_0KeQ
  priority: 102
  providerName: ProQuest
Title Association between the expression of TLR4, TLR2, and MyD88 with low-grade chronic inflammation in individuals with metabolically healthy obesity
URI https://link.springer.com/article/10.1007/s11033-023-08338-z
https://www.ncbi.nlm.nih.gov/pubmed/36905405
https://www.proquest.com/docview/2807223446
https://www.proquest.com/docview/2786101466
https://www.proquest.com/docview/3153178315
Volume 50
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fa9swED7WlrG-lK375a4LGuxtMVi2LNmPWZeubGsZpYHsyVg6uQwyuzQpW_pf9D_uybKTjW6FvVgYn43QffKdpLv7AN5WkhuNLnoGcxUKMpGhpqUQzfgssWllKmzJYI5P5NFEfJqm0y4pbN5Hu_dHku2fep3sxh3vGNkYV1GZpun1Bmylbu1OKJ7Eo3U2JG_L6zpfPxTkUHSpMn__xp_m6I6Peed8tDU7h49hp_MX2cgr-Ak8sPUuPPQMkstdeHTQE7Y9hZvfhpp18VeM_Dtmf3XRrjVrKnb25VQM3TUesrJGdrz8kGXM7ceyWfMzPL8s0TLja-Yywh9Bxqc30g37vsrfmvtXftgFwcjt_M1mS-azKpes8XQDz2ByOD47OAo7xoXQiChbhFxiFqnKSiNtZLW0qTY8z7WtjJCJEQYj5BjLHKMIhZFk3pRGiaRSYRMVJ89hs25q-xKYUgqN4Ry5rkSKquSYlHlkNAHA8DgOgPcDX5iuHLljxZgV60LKTlkFKatolVVcB_Bu9c6FL8Zxr_R-r8-im5jzwhX_IY-IFsEBvFk9JkW5c5Kyts0VyahMOgpjeY9MQpaCq4yaAF54rKy6lMi8dYQDGPbgWXfg3_3d-z_xV7Adt0B2wZf7sLm4vLKvyUFa6AFsqKkawNbo47fPY2rfj0--ng7aWXIL2agL_Q
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB5VqVC5ICgvQ4FFghOx8NqbtX1ACPpQSpMIVanUm_HurBFSsEuTqrj_gj_Cb2TWayegitx6SRRlHY0y385jd2Y-gFeF5FqhrZ7BNPYFuUhfUSpEOz6JzKDQBTZkMOOJHJ6IT6eD0w343fXC2LLKziY2hhorbc_I39qpLeTKKHt5f_bDt6xR9na1o9BwsDgy9SWlbPN3h3uk39dheLA_3R36LauAr0WQLHwukX6qMFJLExglzUBpnqbKFFrISAuNAXIMZYpBgEJLMuGxQokktjBRbAcdkMnfFBGlMj3Y_Lg_-Xy86sTkzWhfm2f4goKZtk3HNetxy5tGPtJOhCYzc_WvK7wW3167m21c3sFduNPGquyDA9c92DDlNtxy7JX1NmztdmRx9-HXX2pmbe0Xo9iSmZ9tpW3JqoJNR8eib1_DPstLZON6L0mYPQtms-rS_3qeo2HazetlhH2Cq2utpA_s27J3bO4e-W4WBGF76jib1cx1dNasclQHD-DkRvTyEHplVZrHwOI4Rq05R64KMcA45xjlaaAVgU_zMPSAd398pttR6JaRY5athjhbZWWkrKxRVnblwZvlM2duEMja1TudPrPWKMyzFYQ9eLn8mhRl72jy0lQXtCZOpKVPlmvWROSleJzQmwePHFaWIkUybYJwD_odeFYC_F_eJ-vlfQFbw-l4lI0OJ0dP4XbYgNgWfe5Ab3F-YZ5RYLZQz9vdwODLTW_AP2EhSlw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB5VRTwuqBQooQWMBCc2apw4dnJACHVZtfQhhFppbyGxHYS0JKW7VUn_Rf8Ov64zcbILqthbLxut1omcnW8etmfmA3hTSq4LQ9kzJlW-QBfpF7gUQo1PIhuXujQtGczhkdw9EZ_H8XgF_vS1MJRW2dvE1lCbWtMe-TZ1bUFXhquX7bJLi_gyHH04_eUTgxSdtPZ0Gg4i-7a5wOXb9P3eEGX9NgxHn453dv2OYcDXIkhmPpcGH1taqaUNbCFtXGiepoUttZCRFtoEhptQpiYIjNASzbkqjDT4CsJGipoeoPm_o6KYk46psVrUZPK2yS-tOHyBYU1XsOPK9jgxqKG3pN7QaHAu_3WKNyLdG6e0rfMbrcHDLmplHx3MHsGKrdbhruOxbNbh_k5PG_cYrv4SOOuywBhGmcz-7nJuK1aX7PjgqxjQZzhgeWXYYTNMEka7wmxSX_jfz3JjmXadexlqAQLXFVniF_ZjXkU2dbf8tDMEM-0_TiYNc7WdDasd6cETOLkVqTyF1aqu7DNgSimjNeeGF6WIjcq5ifI00AXCUPMw9ID3f3ymu6boxM0xyRbtnElYGQora4WVXXrwbn7PqWsJsnT0Vi_PrDMP02wBZg9ez39GQdFpTV7Z-hzHqEQSkbJcMiZCf8VVghcPNhxW5lOKZNqG4x4MevAsJvD_-T5fPt9XcA_VLjvYO9rfhAdhi2HK_tyC1dnZuX2BEdqseNmqAoNvt6171yAsTSw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+the+expression+of+TLR4%2C+TLR2%2C+and+MyD88+with+low-grade+chronic+inflammation+in+individuals+with+metabolically+healthy+obesity&rft.jtitle=Molecular+biology+reports&rft.au=Guerrero-Romero%2C+Fernando&rft.au=Castellanos-Ju%C3%A1rez%2C+Francisco+X.&rft.au=Salas-Pacheco%2C+Jose+M.&rft.au=Morales-Gurrola%2C+Francisco+G.&rft.date=2023-05-01&rft.pub=Springer+Netherlands&rft.issn=0301-4851&rft.eissn=1573-4978&rft.volume=50&rft.issue=5&rft.spage=4723&rft.epage=4728&rft_id=info:doi/10.1007%2Fs11033-023-08338-z&rft.externalDocID=10_1007_s11033_023_08338_z
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0301-4851&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0301-4851&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0301-4851&client=summon